October 19, 2021

Reducing Wound Healing Complications After Resection of Soft Tissue Sarcoma

Studies investigate two potential risk-prediction methods

21-ORI-2349759 CQD 650×450

Soft tissue sarcomas are serious but potentially treatable cancers. Radiation therapy and limb-salvage surgical resection can be curative if the disease is localized.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Radiation therapy can be given either before or after surgery. Typically, it is done first in order to kill microscopic disease around the tumor to make removal safer around critical structures. Preoperative radiation therapy uses a smaller dose compared to postoperative treatment and results in better overall limb function.

“Unfortunately, radiation can cause collateral damage, which can lead to wound healing complications after surgery,” says orthopaedic surgeon Lukas Nystrom, MD, who specializes in orthopaedic oncology at Cleveland Clinic.

In one study, such complications occurred in about 35% of all cases and 43% with lower extremity tumors, compared to just 17% of patients who received postoperative radiation.

“Patients who experience complications have a significantly diminished quality of life as measured by our patient-reported outcome instruments,” says Dr. Nystrom. “The situation can persist for many months. We can manage it, but it involves multiple trips to the operating room, a ton of extra medical visits, increased pain and a lot of psychological distress.”

Prediction could lead to prevention

To reduce wound healing complications following resection of soft tissue sarcoma, Dr. Nystrom is leading a team at Cleveland Clinic that is exploring methods for identifying patients who may be at greater risk.

Advertisement

“If we can determine up front which patients are going to have trouble with wound complications, then we can potentially take steps to avoid it and improve their experience,” he says.

Techniques to reduce the risk of wound healing complications potentially include altering the timing of surgery, vacuum-assisted closure, hyperbaric oxygen therapy and using surgical flaps in areas where healing potential is compromised.

Method 1: transcutaneous oximetry

There currently are no reliable laboratory or clinical criteria to predict which patients are more likely to develop wound healing complications.

Dr. Nystrom and his colleagues are investigating two methods to help with that prediction: transcutaneous oxygen (TcO2) measurement at the surgical site to determine skin perfusion, and near-infrared fluorescence imaging with indocyanine green (ICG).

The team has already completed a prospective study of transcutaneous oximetry in 39 patients, finding a trend toward decreased TcO2 in those who had wound healing complications, although it was not statistically significant. Dr. Nystrom hypothesizes that this may be related to sampling a very limited area of the surgical resection. These data were presented at the 2021 Musculoskeletal Tumor Society Annual Meeting and are currently being prepared for publication.

Advertisement

Method 2: ICG fluorescence imaging

Potentially more informative is ICG, a fluorescent biomarker that has been used for intraoperative assessment of perfusion in plastic reconstruction surgery, for identification of lymph nodes and in assessment of cardiac function.

A recently launched prospective study aims to enroll 50 patients with biopsy-proven soft tissue sarcoma of the upper or lower extremity to be treated with limb-salvage surgical excision. It is the first investigation trying to quantify tissue perfusion and relate it to post-surgical wound healing in this patient population, says Dr. Nystrom.

Related Articles

Doctor measuring patient's waist size
February 26, 2024
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access

How antibody drug conjugates work
February 13, 2024
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

CQD-CHP4445461-hanna-sickle-650×450
February 5, 2024
Haploidentical Bone Marrow Transplant Has Durable Engraftment in Patients With Sickle Cell Disease

Two-year event-free survival comparable to matched sibling donor myeloablative transplant

24-CNR-4545611-CQD-Podcast-967×544
February 1, 2024
Possibilities of CRISPR Technology (Podcast)

Gene editing technology offers promise for treating multiple myeloma and other hematologic malignancies, as well as solid tumors

CQD-CHP4445460-hanna-sickle-650×450
January 30, 2024
Gene Therapy Trials Show Positive Results in Sickle Cell Disease and Thalassemia

First-in-human trials of CRISPR-Cas12a gene editing demonstrate safety and meaningful event-free survival

photo of Elekta Esprit Gamma Knife machine
January 26, 2024
The Evolution of Gamma Knife Technology (Podcast)

Improvements enable targeting of brain tumors with single-session, fractionated or neoadjuvant approaches

Ad